Antismoking agents do not contribute synergistically to semaglutide’s ability to reduce alcohol intake in rats

Antismoking agents do not contribute synergistically to semaglutide’s ability to reduce alcohol intake in rats

Preclinical studies have identified glucagon-like peptide-1 receptor (GLP-1R) agonists, and the antismoking agents varenicline and bupropion as tentative agents for treatment of alcohol use disorder (AUD). Combining different medications is a recent approach that has gained attention regarding heter...

Full description

Bibliographic Details
Main Authors: Cajsa Aranäs, Sebastian Blid Sköldheden, Elisabet Jerlhag
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Pharmacology
Subjects:
GLP-1
alcohol dependence
dopamine
smoking
reward
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1180512/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1180512/full

Similar Items